Insight & Intelligence

More »

GEN Podcasts

The Sounds of Science podcast is brought to you by GEN. Listen as members of the editorial team—Editor-in-Chief John Sterling, Technical Editor Jeff Buguliskis, and Senior News Editor Alex Philippidis—showcase innovative research, new initiatives, and important policy by interviewing thought-leaders, eminent life-science researchers, and company leaders. These short, but informative podcasts will keep you up-to-date with the latest and most important life science advances.

May 31, 2018

CEM Corp.’s Primary Focus: Solid-phase Peptide Synthesis

Microwave technology for peptide synthesis relies on company’s Liberty series of products. Methodology was designed to reduce reaction rates and waste production.

April 30, 2018

Advancing Gene Therapy

OriGene's goal is to enable more detailed insights into stem-cell research and into disease mechanisms, such as those that lead to cancer. In this sponsored podcast, GEN spoke to Minjun Liu, Ph.D., marketing director for OriGene.

February 13, 2018

New York City Goes for Biotech Gold

Raphael Farzan-Kashani, a director with the New York City Economic Development Corp., discusses the city’s plans for a $100 million Applied Life Sciences Hub—part of a 10-year, $500 million plan to attract 16,000 new life-sci jobs and catapult the Big Apple into a top-tier biopharma cluster.

January 25, 2018

Transforming the Bioresearch and Healthcare Industries

Having the right data and knowing how to use it will be the key to success in the healthcare market in the future.

November 27, 2017

Inhibiting Cancer Metastasis

Canadian team identifies protein that when hindered decreases invasion rate of cancer cells.

October 23, 2017

New Method Developed for Growing Tissue Engineered Corneas

Researchers discovered that corneal cells isolated from human donors and grown on a dome-shaped surface behaved differently than those on flat one. There are a number of advantages to using such curved substrates.

September 15, 2017

Millipore Says It is Bullish on Continuous Bioprocessing

Millipore is using its expertise in biomanufacturing to take advantage of the growing interest in continuous or next generation bioprocessing. The company is investing in specific technologies in terms of dedicated teams, focused R&D efforts, and product-development projects.

July 31, 2017

New Drug Delivery Materials May Help Patient Compliance with Meds

Researchers at MIT and Brigham and Women's Hospital create triggerable tough hydrogels. Hydrogels may last in stomach for lengthy periods of time.

July 18, 2017

Looking at the CAR-T Landscape As First Approval Nears

Brad Loncar, CEO of Loncar Investments, discusses the outlook for chimeric antigen receptor T cell (CAR-T) cancer therapies as Novartis nears FDA approval for the first such treatment, CTL019. Some other CAR-T therapies have also shown early, yet promising, clinical data.

June 28, 2017

SARS and MERS Inhibited by Ebola Drug

A research team from Vanderbilt University, University of North Carolina, and Gilead Sciences has just released new findings in Science Translational Medicine that a new antiviral drug candidate inhibits a broad range of coronaviruses, including SARS and MERS.

June 19, 2017

Bioengineers Use Quantum Dots to Help Develop New Therapies for Multiple Sclerosis

Team believes a rational therapeutic design approach will allow scientists to transform how the disease is tackled. Quantum dot technology also should be applicable to other autoimmune diseases as well.

May 30, 2017

Soft Tissue Synthetic Retina Created

A synthetic, soft tissue retina developed by an Oxford University doctoral chemistry student could offer fresh hope for visually impaired people.

May 18, 2017

FDA’s New Commissioner Hits the Ground Running

Sara Radcliffe, President and CEO of the California Life Sciences Association, discusses where Scott Gottlieb, M.D., is most likely to impact biopharma, and what the industry hopes he will accomplish as the FDA’s new commissioner.

May 4, 2017

New Zika Test Shines LAMP in the Dark

A new test not only rapidly and inexpensively detects Zika virus in mosquitoes and human bodily fluids, but can also distinguish between African and Asian strains.

April 14, 2017

Inflammation-Sensing Gut Bacteria Brought to You by Synthetic Biology

New research may eventually lead to orally ingestible bacteria for monitoring gut health and disease—with the ultimate goal being the development of a home inflammation test.

April 10, 2017

Standing Up Against NIH Budget Cuts

Mary Woolley, President of Research!America, which advocates for medical and health research funding, talks about how her group and other advocates plan to fight back against President Donald Trump’s one-two punch to NIH funding. Researchers will be key to those efforts, she says.

April 3, 2017

Is Maple Syrup the Answer to Antibiotic Resistance?

McGill University researchers may have found a natural way to cut down on antibiotic use without sacrificing health.

March 16, 2017

Sensitive Genotypes and their Impact on Economic Success

A recent study suggest that children with sensitive genotypes who come from low-income homes will be less financially successful than their same sex sibling without those genotypes. But children with those same genotypes from a high-income home would actually fare better economically as young adults than their brother or sister.

March 9, 2017

Cancer Immunotherapy: CAR T as 'Car Race'

Brad Loncar, CEO of Loncar Investments, weighs in on recent developments in the scramble to develop CAR T cancer immunotherapies. How significant a setback is Juno Therapeutics’ halting development of JCAR015? How could some second-tier companies yet come out on top in the “car race”?

February 28, 2017

Cannibalism: A Biological and Evolutionary Perspective

Scientists have long written off cannibalism as a strange phenomenon with little biological significance. However, the true nature of cannibalism—the role it plays in evolution as well as human history—is even more intriguing (and more normal) than the misconceptions we’ve come to accept as fact.